These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24385723)

  • 1. The Dual Diverse Dynamic Reversible Effects of Ankaferd Blood Stopper on EPCR and PAI-1 Inside Vascular Endothelial Cells With and Without LPS Challenge.
    Karabıyık A; Yılmaz E; Güleç S; Haznedaroğlu I; Akar N
    Turk J Haematol; 2012 Dec; 29(4):361-6. PubMed ID: 24385723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible protease-activated receptor 1 downregulation mediated by Ankaferd blood stopper inducible with lipopolysaccharides inside the human umbilical vein endothelial cells.
    Karabiyik A; Güleç S; Yilmaz E; Haznedaroglu I; Akar N
    Clin Appl Thromb Hemost; 2011; 17(6):E165-70. PubMed ID: 21406410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).
    Ciftciler R; Ciftciler AE; Malkan UY; Haznedaroglu IC
    SAGE Open Med; 2020; 8():2050312120907811. PubMed ID: 32110403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of Ankaferd® Blood Stopper on transcription factors in HUVEC and the erythrocyte protein profile.
    Yılmaz E; Güleç Ş; Torun D; Haznedaroğlu İC; Akar N
    Turk J Haematol; 2011 Dec; 28(4):276-85. PubMed ID: 27264584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of hemostatic effects of Ankaferd as an alternative medicine.
    Beyazit Y; Kurt M; Kekilli M; Goker H; Haznedaroglu IC
    Altern Med Rev; 2010 Dec; 15(4):329-36. PubMed ID: 21194248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Ankaferd on anastomotic healing of colon.
    Cancan G; Teksoz S; Aytac E; Arikan AE; Erman H; Uzun H; Ozden F; Aydin O; Ozcan M
    J Invest Surg; 2014 Feb; 27(1):1-6. PubMed ID: 23987308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo hemostatic effect of the medicinal plant extract Ankaferd Blood Stopper in rats pretreated with warfarin.
    Cipil HS; Kosar A; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Koroglu M; Kirazli S; Firat HC
    Clin Appl Thromb Hemost; 2009; 15(3):270-6. PubMed ID: 19117967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interaction potential of Ankaferd blood stopper® in human hepatocarcinoma cells.
    Semiz A
    Turk J Med Sci; 2023 Apr; 53(2):455-462. PubMed ID: 37476879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional proteomic analysis of Ankaferd® Blood Stopper.
    Özel Demiralp D; Haznedaroglu İC; Akar N
    Turk J Haematol; 2010 Jun; 27(2):70-7. PubMed ID: 27263447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper.
    Goker H; Haznedaroglu IC; Ercetin S; Kirazli S; Akman U; Ozturk Y; Firat HC
    J Int Med Res; 2008; 36(1):163-70. PubMed ID: 18304416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic and transcriptomic analyses to explain the pleiotropic effects of Ankaferd blood stopper.
    Simsek C; Selek S; Koca M; Haznedaroglu IC
    SAGE Open Med; 2017; 5():2050312117722569. PubMed ID: 28839937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraarticular Ankaferd blood stopper application increases cartilagedegeneration: an experimental study.
    Kaya İ; Gülabi D; Yilmaz M; Baş A; Çeçen GS; Şener N
    Turk J Med Sci; 2016 Jan; 46(1):236-40. PubMed ID: 27511359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ankaferd hemostat in the management of gastrointestinal hemorrhages.
    Beyazit Y; Kekilli M; Haznedaroglu IC; Kayacetin E; Basaranoglu M
    World J Gastroenterol; 2011 Sep; 17(35):3962-70. PubMed ID: 22046083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
    Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbon monoxide-releasing molecule-2 suppresses thrombomodulin and endothelial protein C receptor expression of human umbilical vein endothelial cells induced by lipopolysaccharide in vitro.
    Meng X; Fei D; Liu M; Yang S; Song N; Jiang L; Kang K; Nan C; Luo Y; Pan S; Zhao M
    Medicine (Baltimore); 2017 May; 96(21):e6978. PubMed ID: 28538400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.
    Schleef RR; Loskutoff DJ; Podor TJ
    J Cell Biol; 1991 Jun; 113(6):1413-23. PubMed ID: 2045419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ankaferd blood stopper in episiotomy repair.
    Eyi EG; Engin-Ustün Y; Kaba M; Mollamahmutoğlu L
    Clin Exp Obstet Gynecol; 2013; 40(1):141-3. PubMed ID: 23724529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the chemopreventive effects of Ankaferd Bloodstopper in 7,12-dimethylbenz[a]anthracene-induced oral epithelial dysplasia.
    Ozle M; Uğar Çankal DA; Ilhan M; Keleş H; Küpeli Akkol E
    Clin Oral Investig; 2018 Dec; 22(9):3091-3096. PubMed ID: 29500540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of ligustrazini against thrombosis.
    Song J; Ruan Q
    Chin Med J (Engl); 2000 Feb; 113(2):136-9. PubMed ID: 11775537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper gastrointestinal bleeding in a patient with defective hemostasis successfully treated with ankaferd blood stopper.
    Purnak T; Ozaslan E; Beyazit Y; Haznedaroglu IC
    Phytother Res; 2011 Feb; 25(2):312-3. PubMed ID: 20677211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.